Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed Review

Tumor metastasis to bone

Mandeep S Virk and Jay R Lieberman*

Arthritis Research & Therapy 2007, 9(Suppl 1):S5  doi:10.1186/ar2169

Article Metrics

10195
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 126 accesses
  • Last 365 days: 820 accesses
  • All time: 10195 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information